ADM Biopolis - Full support for probiotic product development

ADM Biopolis provides state-of-the-art microbial technologies for the food and pharmaceutical sectors. It partners with its customers at every stage of product development, achieving flexible customer engagement options to improve business competitiveness:

• Discovery and identification of the strain: sourcing from breast milk of faeces of healthy babies up to three months old, species identification (16s rRNA) and whole genome sequencing.
• Functionality screening and validation: survival under physiological conditions, including pH and bile salts, and target functionality using in-vitro models, animal models and clinical trials.
• Safety analysis: in-vitro and in-vivo studies following EFSA and WHO/FAO guidelines, including antibiotic resistance, toxins and pathodenicity, animal models and additional testing upon request.
• Scale-up: optimisation of the production parameters from 1L to pilot, freeze-drying, specific formulations and stability testing.
• Production: industrial production scale and freezedrying; packaging; GMP, kosher and halal; non-GMO and vegan; and FSMA-compliant.

Therefore, ADM Biopolis offers a variety of engagements with customers, from directed microbial design and proof of concept evaluation, to fermentation scale-up in pilot and manufacturing plants.

Its proprietary high throughput evaluation system allows ADM Biopolis to screen for optimal strain and ingredient formulations.

Range of technology and products

ADM Biopolis has a growing portfolio of off-the-shelf conventional and functional probiotics carefully developed following FAO/WHO guidelines, and supported by safety and clinical studies. Its production facility in Spain is certified ISO 22000 allergen-free, non-GMO and halal. It provides tested stability data and storage recommendations for every strain.

Specialising in microbial technologies, ADM Biopolis has a wide range of speciality probiotic ingredients, designed to aid product developers and formulators looking to create health-targeted products. From conventional probiotic strains for immune and digestive health, to proprietary, tailored strains and blends for skin health, infant nutrition, sports nutrition or metabolic syndrome, ADM Biopolis is able to demonstrate how it can support its partners in probiotic research, including selection and identification, all the way through to scale-up and production.

Diversity of markets

Moreover, being part of ADM allows Biopolis to leverage ADM's current functional portfolio of ingredients, opening a door to new health areas and indications. This way, ADM Biopolis is able to provide its customers with different final product applications.

As per the diversity of all the applications that ADM Biopolis can offer, it is crucial to match the target market and the customer goals. ADM Biopolis works in many markets, including:

• baby food
• cereals and protein bars
• dairy products
• dietary supplements
• frozen desserts
• animal nutrition
• chilled and instant beverages
• confectionery.

In addition to this, ADM Biopolis - acting as a one-stop shop - offers integral product development, ingredient delivery technologies for ingredient delivery and suitable product matrices, and the latest news on functionality, as well as regulatory guidance.

ADM Biopolis is the microbiome and biotech solutions provider for the industry, seeking to act as the voice of expertise and reference. It was created to transfer the knowledge and technology of microbial research to the needs of today's world. It has constantly pushed the boundaries of technology and knowledge in the latest biotechnology innovations, making its staff pioneers and game-changers.